Jerold Grupp appointed vice-president of Phlexglobal
This article was originally published in Scrip
Phlexglobal, a CRO for TMF and eTMF management, has appointed Jerold Grupp vice-president. In addition, Mr Grupp will head up the organisation's Philadelphia office, which opened in May. Mr Grupp has 20 years' experience at companies including Johnson and Johnson, Schering-Plough, Medidata Solutions and ICON Central Laboratories.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.